Fibromyalgia wrecked young solicitor's life until low-dose drug helped.

TL;DR

Young solicitor Ivy Ganguly's life unravelled from fibromyalgia after a fever, with pain halting daily tasks and exams.
Studies from Mount Sinai, Yale, and Aberdeen link over 40 genetic variants to faulty pain processing in fibromyalgia patients.
Genetic findings counter stigma, support symptom management via exercise, CBT, and low-dose drugs like amitriptyline.

The story at a glance

Trainee solicitor Ivy Ganguly, 22, from London, describes how fibromyalgia wrecked her life after a fever in Morocco in 2023, causing severe pain, fatigue, and isolation. Expert Professor Gary Macfarlane discusses new studies showing genetic variants behind the condition's oversensitive pain systems, plus management strategies. The piece is reported now amid fresh research from Mount Sinai Hospital Toronto, Yale University, and University of Aberdeen highlighting biological roots. Fibromyalgia affects 1 in 50 Britons, but stigma and poor diagnosis delay help.

Key points

Ivy developed crushing fatigue, sleeplessness, and bone-like pain after a fever; couldn't bend, use transport, or socialise, passing her solicitors exam but bedridden after.
Initial GP dismissed as hormones; NHS rheumatologist diagnosed fibromyalgia but offered no cause or cure, just exercise and sleep advice.
Low-dose amitriptyline from London Pain Clinic cut pain within hours, allowing walks, Peloton sessions, and pilates; she paces energy but weekends recovering.
Two studies assessed over 1 million patients, finding more than 40 genetic variants tied to abnormal brain and nervous system pain processing.
University of Aberdeen's PACFiND project on 100,000+ NHS records shows treatment varies by area, from multidisciplinary clinics to just painkillers.
Symptoms include widespread pain over 3 months, tender areas, fatigue, poor sleep; overlaps chronic fatigue, arthritis; average 3 years to diagnosis.
Professor Macfarlane: oversensitive nerves from stress or trauma; gentle movement, CBT, and education retrain system, with one trial showing lasting benefits for a third of patients.

Details and context

Fibromyalgia has no single test or cure; diagnosis rules out other causes per Royal College guidelines. Triggers like infections or stress may play a role, but evidence is weak; nerves fire wrongly, brain stays in high alert.

Stigma persists: a 2025 survey found some GPs view it as anxiety-driven; Fibromyalgia Action UK says denial leaves patients bedbound, jobless, isolated.

Treatments focus on quality of life: start slow with walking or stretching to avoid weakening; CBT teaches pain isn't always damage, cuts stress; access limited by waits and few therapists.

Key quotes

"My body just shut down after that," says Ivy Ganguly.
"I know I’ll never be 100 per cent – but I’m in control again," Ivy adds.[[1]](https://www.dailymail.co.uk/health/article-15264713/Faulty-gene-fibromyalgia-chronic-painful-condition-doctors.html)[[2]](https://www.dailymail.co.uk/health/article-15279855/GP-dismisses-symptoms-hormones-DR-KAYE-fibromyalgia.html)

Why it matters

Millions endure fibromyalgia's pain and fatigue, but genetic evidence proves it's biological, not imagined, challenging doctors to take it seriously. Patients gain hope from proven steps like low-dose drugs and paced exercise, easing symptoms enough for work and life. Watch for better therapies as research into these genes advances, though access to multidisciplinary care varies widely.